Health PR Newswire NUTEX HEALTH OPENS ARCHVIEW ER & HOSPITAL IN ST. LOUIS rvrisingnetwork December 29, 2025 HOUSTON, Dec. 22, 2025 /PRNewswire/ — Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX),…
Health PR Newswire Healthcare IT Market Set to More Than Double by 2030 Growing at 15.24% CAGR, Reports Mordor Intelligence rvrisingnetwork December 18, 2025 HYDERABAD, India, December 15, 2025 /PRNewswire/ — According to Mordor Intelligence, the healthcare IT market …
Health PR Newswire Beauty Health Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of The Beauty Health Company rvrisingnetwork November 24, 2025 NEW YORK and NEW ORLEANS, Nov. 21, 2025 /PRNewswire/ — Former Attorney General of Louisiana,…
Health PR Newswire Molina Healthcare, Inc. Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights rvrisingnetwork November 24, 2025 LOS ANGELES, Nov. 24, 2025 /PRNewswire/ — The DJS Law Group reminds investors of a…
Health PR Newswire Lung Association Steps Up with $22 Million in Research Funding as Federal Support for Science Wavers rvrisingnetwork October 29, 2025 American Lung Association invests in leading scientists researching lung disease and lung cancer CHICAGO, Oct.…
Health PR Newswire Health Canada Grants Authorization for Leqembi® (lecanemab) rvrisingnetwork October 27, 2025 STOCKHOLM, Oct. 27, 2025 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced…
Health PR Newswire VARON Supports Respiratory Wellness During Seasonal Change rvrisingnetwork October 25, 2025 NEW YORK, Oct. 24, 2025 /PRNewswire/ — As cooler temperatures and shifting air quality arrive,…
Health PR Newswire Molina Healthcare, Inc. (MOH) Investors: December 2, 2025 Filing Deadline in Securities Class Action rvrisingnetwork October 23, 2025 RADNOR, Pa., Oct. 22, 2025 /PRNewswire/ — The law firm of Kessler Topaz Meltzer &…
Health PR Newswire FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy’s Disease rvrisingnetwork October 23, 2025 TAIPEI, Oct. 22, 2025 /PRNewswire/ — AnnJi Pharmaceutical Co., Ltd. (AnnJi, TWSE: 7754) today announced…
Health PR Newswire FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy’s Disease rvrisingnetwork October 23, 2025 TAIPEI, Oct. 23, 2025 /PRNewswire/ — AnnJi Pharmaceutical Co., Ltd. (AnnJi, TWSE: 7754) today announced…